The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
and there are lots of things that we can speculate on this front certainly one of them is people that have more ace 2 receptors which if you go back to the very first or second question we talked about how the ACE 2 receptor is potentially a portal by which the virus gains access to the cell called the type 2 nimah site where we think it's doing the majority of its damage
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.